A study of how chemical modification of DNA in hESCs impacts nerve formation and the ability of stem cells to repair brain damage caused by stroke (UCLA)
Development of new ways of deriving hESCs and investigating the special capabilities of newly-derived human cell lines. (UCSF)
A proposal to develop neural cellular models of Parkinson’s disease and Lou Gehrig’s disease (ALS) that could be used to screen chemical libraries for novel drugs and to develop preclinical models of human disease (Salk Institute)
Building tools to better isolate heart and blood cells from differentiated populations of hESCs (Stanford)
A proposal to optimize the creation of liver cells for transplantation, and be able to monitor their in-vivo fate non-invasively (UC Davis)
A study of molecular mechanisms regulating hESC survival, focused on a very specific and promising class of growth factors (UC Irvine)
Last month, the agency distributed $45 million for stem cell research projects.
